| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |